1. Home
  2. IDT vs SLS Comparison

IDT vs SLS Comparison

Compare IDT & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDT Corporation Class B

IDT

IDT Corporation Class B

N/A

Current Price

$77.30

Market Cap

1.5B

ML Signal

N/A

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

N/A

Current Price

$19.57

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IDT
SLS
Founded
1990
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
1996
2007

Fundamental Metrics

Financial Performance
Metric
IDT
SLS
Price
$77.30
$19.57
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $37.50
AVG Volume (30 Days)
128.6K
★ 10.8M
Earning Date
12-03-2026
11-12-2026
Dividend Yield
★ 0.36%
N/A
EPS Growth
14.95
★ 50.00
EPS
★ 3.46
N/A
Revenue
★ $1,231,495,000.00
N/A
Revenue This Year
$2.39
N/A
Revenue Next Year
$0.75
N/A
P/E Ratio
$22.47
★ N/A
Revenue Growth
★ 2.13
N/A
52 Week Low
$46.48
$1.39
52 Week High
$84.56
$24.89

Technical Indicators

Market Signals
Indicator
IDT
SLS
Relative Strength Index (RSI) 38.45 77.39
Support Level $51.16 $11.40
Resistance Level $84.48 N/A
Average True Range (ATR) 2.14 1.63
MACD -0.86 1.10
Stochastic Oscillator 14.00 70.00

Price Performance

Historical Comparison
IDT
SLS

About IDT IDT Corporation Class B

IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: